Bile acids for metabolic dysfunction-associated steatotic liver disease in adults

Rehab E. Ashmawy; Oleg Blyuss; Dimitrinka Nikolova; Chavdar S. Pavlov; Christian Gluud; Paola J. Andrenacci

doi:10.1002/14651858.CD014850

Bile acids for metabolic dysfunction-associated steatotic liver disease in adults

Rehab E. Ashmawy^*
, Oleg Blyuss
, Dimitrinka Nikolova
, Chavdar S. Pavlov
, Christian Gluud
, Paola J. Andrenacci

^*Kontaktforfatter

Helwan University
Queen Mary University of London
Sechenov University
Rigshospitalet
Botkin Hospital
The Cochrane Hepato-Biliary Group, Argentina

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

10 Downloads (Pure)

Abstract

OBJECTIVES: This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of oral bile acid-based therapies versus no intervention or placebo, or versus a different bile acid-based therapy, at any dose or regimen, in adults diagnosed with metabolic dysfunction-associated steatotic liver disease (MASLD).

Originalsprog	Engelsk
Artikelnummer	CD014850
Tidsskrift	The Cochrane database of systematic reviews
Vol/bind	9
Antal sider	17
ISSN	1469-493X
DOI	https://doi.org/10.1002/14651858.CD014850
Status	Udgivet - 2. sep. 2025

Bibliografisk note

Publisher Copyright:
Copyright © 2025 The Authors. Cochrane Database of Systematic Reviews published by John Wiley & Sons, Ltd. on behalf of The Cochrane Collaboration.

Dokumenter og links

10.1002/14651858.CD014850Licens: CC BY-NC

Open Access VersionForlagets udgivne version, 271 KBLicens: CC BY-NC

SDU link

Tjek adgangen til materialet i Syddansk Universitetsbiblioteks søgemaskine

Citationsformater

@article{5ddeb0ae5c21406790b7c80d8ae99278,

title = "Bile acids for metabolic dysfunction-associated steatotic liver disease in adults",

abstract = "OBJECTIVES: This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of oral bile acid-based therapies versus no intervention or placebo, or versus a different bile acid-based therapy, at any dose or regimen, in adults diagnosed with metabolic dysfunction-associated steatotic liver disease (MASLD).",

author = "Ashmawy, \{Rehab E.\} and Oleg Blyuss and Dimitrinka Nikolova and Pavlov, \{Chavdar S.\} and Christian Gluud and Andrenacci, \{Paola J.\}",

note = "Publisher Copyright: Copyright {\textcopyright} 2025 The Authors. Cochrane Database of Systematic Reviews published by John Wiley \& Sons, Ltd. on behalf of The Cochrane Collaboration.",

year = "2025",

month = sep,

day = "2",

doi = "10.1002/14651858.CD014850",

language = "English",

volume = "9",

journal = "The Cochrane database of systematic reviews",

issn = "1469-493X",

publisher = "Wiley",

}

TY - JOUR

T1 - Bile acids for metabolic dysfunction-associated steatotic liver disease in adults

AU - Ashmawy, Rehab E.

AU - Blyuss, Oleg

AU - Nikolova, Dimitrinka

AU - Pavlov, Chavdar S.

AU - Gluud, Christian

AU - Andrenacci, Paola J.

PY - 2025/9/2

Y1 - 2025/9/2

N2 - OBJECTIVES: This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of oral bile acid-based therapies versus no intervention or placebo, or versus a different bile acid-based therapy, at any dose or regimen, in adults diagnosed with metabolic dysfunction-associated steatotic liver disease (MASLD).

AB - OBJECTIVES: This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of oral bile acid-based therapies versus no intervention or placebo, or versus a different bile acid-based therapy, at any dose or regimen, in adults diagnosed with metabolic dysfunction-associated steatotic liver disease (MASLD).

U2 - 10.1002/14651858.CD014850

DO - 10.1002/14651858.CD014850

M3 - Journal article

C2 - 40891522

AN - SCOPUS:105015030079

SN - 1469-493X

VL - 9

JO - The Cochrane database of systematic reviews

JF - The Cochrane database of systematic reviews

M1 - CD014850

ER -

Bile acids for metabolic dysfunction-associated steatotic liver disease in adults

Abstract

Bibliografisk note

Dokumenter og links

SDU link

Fingeraftryk

Citationsformater